Paragon BioTeck, Inc.'s Online Social Networking Platform, Noble Vision Group, Incorporates Treato's Patient-Generated Medical Database

      

Thu, 14 Jun 2012, 15:45:20 EDT
Edited by Debra Tone

TIGARD, Ore., June 14, 2012 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a research and development organization in the eye care industry, today announced that the company's online community discussion forum and blog, Noble Vision Group, has added the revolutionary plug-in, Treato. The plug-in, released to developers in May, 2012, allows users to search Treato's database of over 1 billion patient-generated social media posts, providing important insights into the side effects and efficacy of over 11,000 medications.

Noble Vision Group

TIGARD, Ore., June 14, 2012 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a research and development organization in the eye care industry, today announced that the company's online community discussion forum and blog, Noble Vision Group, has added the revolutionary plug-in, Treato. The plug-in, released to developers in May, 2012, allows users to search Treato's database of over 1 billion patient-generated social media posts, providing important insights into the side effects and efficacy of over 11,000 medications.

Treato's state-of-the-art technological infrastructure was developed in order to deal with the mass amounts of medical data spread throughout the internet. Treato converts patient-reported outcomes published across the web into medically meaningful information. The "Wisdom of the Crowd" concept reflects that large crowds often predict events and/or achieve insights better than individuals or small groups. Learn more about Treato: http://treato.com.

Treato acts as another avenue through which information can be exchanged within the eye care industry using Noble Vision Group's community discussion forum, allowing for collaboration between internet users throughout the world and the medical experts at Noble Vision Group.

Paragon BioTeck, Inc. President and CEO, Patrick H. Witham commented, "The Treato Plug-In is the perfect addition to the Noble Vision Group community discussion forum. We continue to look for new ways to utilize Noble Vision Group in order to increase the amount of valuable conversation and the pace in which it is disseminated within the eye care community. Treato is a tremendous development that provides consumers, practitioners and drug companies amazing insight. I am extremely pleased that Paragon BioTeck, Inc. and Noble Vision Group have the opportunity to participate in delivering this technology to the eye care community."

About Noble Vision Group:

Headquartered in Tigard, Oregon, Paragon BioTeck, Inc.'s, Noble Vision Group is an online community discussion forum and blog directed toward the eye care community. Noble Vision Group was developed and introduced by Paragon BioTeck, Inc. in an effort to cultivate conversation, foster innovation, and create a source where experts and patients can come together to exchange information and expand their knowledge. Learn more at: http://www.noblevisiongroup.com.

Contact:
Paragon BioTeck, Inc.
Jon Banasky, Director of Social Media and Marketing
jbanasky@paragonbioteck.com
(888) 424-1192.

NEWS SOURCE: Paragon BioTeck, Inc.

For more information regarding this press release, please visit:
http://www.noblevisiongroup.com
Send2Press® is the originating wire service for this story “Paragon BioTeck, Inc.'s Online Social Networking Platform, Noble Vision Group, Incorporates Treato's Patient-Generated Medical Database” and content is Copr. © 2012 Paragon BioTeck, Inc. with newswire copy Copr. © 2012 Send2Press (a service of Neotrope). All trademarks acknowledged.

TERMS OF USE: rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
NOTICE: THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE (Paragon BioTeck, Inc.), WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS OR CONCERNS ABOUT THIS NEWS ANNOUNCEMENT, PLEASE CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE.
Reads as of Friday, Apr 25 2014 - 03:37:33 AM EDT:
2685 times (2 today, 11 this week, 64 this month, 290 this year)